VAH Versus VA for Salvage Therapy of R/R-AML

NCT05457361 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Venetoclax Combined With Azacitidine Plus Homoharringtonine
Venetoclax Combined With Azacitidine

Interventions

DRUG: VEN combined with azacitidine plus homoharringtonine
DRUG: VEN combined with azacitidine

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]